.The aim of this study is to identify the analgesic effect of intraoperative ketamine intravenous infusion on patients undergoing intestinal surgery and its effect on salivary cortisol and alpha amylase levels as indicator of its effect.
I- Group K (ketamine): 30 patients will receive intraoperative intravenous ketamine infusion. II- Group C (control): 30 patients will receive intraoperative intravenous normal saline infusion.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
60
intravenous ketamine infusion intraoperatively
intravenous normal saline infusion intraoperatively
morphine consumption
IV PCA
Time frame: 2 days postoperative
cortisol level
salivary
Time frame: 2 days postoperative
alpha amylase level
salivary
Time frame: 2 days postoperative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.